NMT Capital
NMT Capital (”Nexus”) is a globally oriented private equity firm and is currently managing investment funds based in Europe and in the US. Nexus’s portfolio companies are located in both North America and Europe and span the early to late stages of development. Nexus also acts as a consultant to various global investment banks, typically assisting them in sourcing and evaluating private medical companies seeking an acquirer, strategic partner, or growth capital. Nexus is managed by Principals who average more than 20 years of investment management/advisory experience in the fields of medical technology, life science, advanced materials, software, communications, and information technology. They are supported by Advisors and affiliates in Quincy (MA), San Francisco, London, Munich, Geneva, and Tokyo.
Proterra designs and manufactures zero-emission, heavy-duty electric vehicles, enabling bus fleet operators to significantly reduce operating costs while delivering clean, quiet transportation to local communities across North America. The company’s configurable Catalyst platform is designed to serve the daily mileage needs of a wide range of transit routes on a single charge. With industry-leading durability and energy efficiency based on rigorous U.S. independent testing, Proterra products are proudly designed, engineered, and manufactured in America, with offices in Silicon Valley, South Carolina, and Los Angeles. Proterra's revolutionary battery-electric transit vehicles help fleet operators abandon fossil fuels, improve environmental quality, and reduce operating costs. Together with their customers, they have prevented more than 55 million pounds of greenhouse gases from escaping into the atmosphere and avoided burning some 2 million gallons of fuel. The company was established in 2004 and is based in Burlingame, California, USA.
KIYATEC utilizes the patient’s own living tumor cells to create functional 3D models to test a battery of cancer therapies. Its 3DKUBE technology platform conveniently and cost-effectively incorporates perfusion flow, accommodates all scaffold materials, allows in situ imaging, models complex human biology using segregated cell co‐culture, and is a single-use disposable. 3DKUBE cell‐based assays leverage these features to create better in vitro prediction of complex biochemical responses in humans, with a focus on the evaluation of drug toxicity and efficacy prior to use in human clinical trials.
Spectra Analysis, Inc. is a leading supplier of molecular spectroscopy systems and applications for chromatography. Their current products focus on real-time connection of Infrared Spectroscopy to Gas and Liquid Chromatography. Their systems make it possible to collect a full IR spectra for each component in a separation, either as a stand-alone or in parallel with Mass Spectroscopy - fast, reliable and sensitive.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.